EZH2 and breast cancer: As shown in Table 5, the combined genotype of EZH2 rs12670401 (TC + CC) and EZH2 rs6464926 (CT + TT) was significantly associated with the susceptibility to breast cancer (OR =1.465, 95% CI: 1.055–2.036, P=0.022).